Mihael H. Polymeropoulos

President & Chief Executive Officer at Vanda Pharmaceuticals Inc.

Mihael H. Polymeropoulos

Mihael H. Polymeropoulos

President & Chief Executive Officer at Vanda Pharmaceuticals Inc.

Overview
Career Highlights

Vanda Pharmaceuticals Inc.
Integrated Molecular Analysis of Genome Expression

RelSci Relationships

460

Number of Boards

1

Birthday

1960

Age

59

Relationships
RelSci Relationships are individuals Mihael H. Polymeropoulos likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Clinical Development Capital LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Aevi Genomic Medicine, Inc.

Relationship likelihood: Strong

Director at Atterx BioTherapeutics

Relationship likelihood: Strong

Former Partner at Ernst & Young LLP

Relationship likelihood: Strong

Chief Executive Officer at Idera Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chairman at Sapience Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Purfoods LLC

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Benefit Plan Administrator at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Senior Vice President & Chief Commercial Officer at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Paths to Mihael H. Polymeropoulos
Potential Connections via
Relationship Science
You
Mihael H. Polymeropoulos
President & Chief Executive Officer at Vanda Pharmaceuticals Inc.
Education
Unknown

University of Patras is a school in Patras.

Career History
President & Chief Executive Officer
2002 - Current

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vice President & Head-Pharmacogenetics Department
1998 - 2003

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Chief of the Gene Mapping Section, Laboratory of Genetic Disease Research
1992 - 1998

National Human Genome Research Institute engages in genetic and genomic research. It provides guidance to scientific programs and oversees the general operation. The company was founded in 1989 and is headquartered in Bethesda, MD.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$2,500 - $4,999
2010

The George Washington University actively engages Washington, D.C., and the world. Their location in the heart of Washington places them at the core of U.S. government, policy and law. They sit where the worlds of science, technology, media and the arts converge. Their students and faculty have the unparalleled opportunity to study and work alongside leaders and practitioners in every discipline, to take part in the interchanges that shape our community and the world. The George Washington University was created in 1821 through an Act of Congress, fulfilling George Washington’s vision of an institution in the nation’s capital dedicated to educating and preparing future leaders. Today, GW is the largest institution of higher education in the District of Columbia. They have more than 20,000 students—from all 50 states, the District and more than 130 countries—studying a rich range of disciplines: from forensic science and creative writing to international affairs and computer engineering, as well as medicine, public health, the law and public policy. GW comprises three campuses—Foggy Bottom and Mount Vernon in Washington, D.C., and the GW Virginia Science and Technology Campus in Ashburn, Va.—as well as several graduate education centers in the metropolitan area and Hampton Roads, Va.

$1 - $749
2008

The Norwood School, Inc. owns and operates co-educational independent day school. The firm offers lower school, middle school, arts, athletics, character education and service learning, experiential education and intersession, student support services, and high school placement. The company was founded by Frances Brandis Marsh in 1952 and is headquartered in Bethesda, MD.

Political Donations
$200
2002

Ambassador in Residence, Department of Government at American University - School of Public Affairs

Investments
Details Hidden

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mihael H. Polymeropoulos. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mihael H. Polymeropoulos's profile does not indicate a business or promotional relationship of any kind between RelSci and Mihael H. Polymeropoulos.